日本DLBCL队列的简化遗传亚型分类算法及突变特征
该研究对177例日本弥漫性大B细胞淋巴瘤(DLBCL)患者进行144个基因的靶向DNA测序,基于18个代表基因及BCL2、BCL6重排状态开发了简化算法,将DLBCL分为MYD88、NOTCH2、BCL2和SGK1四个遗传亚型。该算法分类结果与已有成熟算法高度一致,四组间预后存在差异,NOTCH2组预后尤其差。研究还揭示了日本患者中CD5阳性DLBCL和甲氨蝶呤相关淋巴增殖性疾病等亚型的未报道遗传特征。
要点
- 简化算法仅需18个代表基因及BCL2/BCL6重排状态即可划分四个遗传亚型。
- 分类结果与已有算法高度一致,四组间预后存在差异,NOTCH2组预后尤其差。
- 揭示了日本DLBCL患者中CD5阳性DLBCL和MTX-LPD的未报道遗传特征。
核心结论
- 基于18个代表基因及BCL2/BCL6重排状态的简化算法可用于DLBCL遗传亚型分类,与已有算法高度一致。
- 四个遗传亚型间预后存在差异,NOTCH2组预后尤其差。
- 研究揭示了日本患者中CD5阳性DLBCL和甲氨蝶呤相关淋巴增殖性疾病的未报道遗传特征。
研究设计与样本
- 回顾性研究,对177例日本DLBCL患者进行144个基因的靶向DNA测序。
- 基于18个代表基因及BCL2和BCL6重排状态开发简化分类算法。
- 在本队列及已发表数据的另一个验证队列中与已有算法进行比较。
主要发现
- 简化算法分类结果与已有算法高度一致。
- 四个遗传亚型组间观察到预后差异,NOTCH2组预后尤其差。
- 发现日本患者中CD5阳性DLBCL和甲氨蝶呤相关淋巴增殖性疾病的未报道遗传特征。
临床怎么用
- 该简化方法可促进DLBCL遗传亚型分类在临床实践中的应用,有助于优化治疗策略。
- 需关注日本DLBCL患者中CD5阳性DLBCL和甲氨蝶呤相关淋巴增殖性疾病的遗传特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent large-scale genetic studies have proposed a new genetic classification of diffuse large B-cell lymphoma (DLBCL), which is clinically and biologically heterogeneous. However, the classification methods were complicated to be introduced into clinical practice. Here we retrospectively evaluated the mutational status and copy number changes of 144 genes in 177 Japanese patients with DLBCL, using targeted DNA sequencing. We developed a simplified algorithm for classifying four genetic subtypes-MYD88, NOTCH2, BCL2, and SGK1-by assessing alterations in 18 representative genes and BCL2 and BCL6 rearrangement status, integrating the significant genes from previous studies. In our cohort and another validation cohort from published data, the classification results in our algorithm showed close agreement with the other established algorithm. A differential prognosis among the four groups was observed. The NOTCH2 group showed a particularly poorer outcome than similar groups in previous reports. Furthermore, our study revealed unreported genetic features in the DLBCL subtypes that are mainly reported in Japanese patients, such as CD5-positive DLBCL and methotrexate-associated lymphoproliferative disorders. These results indicate the utility of our simplified method for DLBCL genetic subtype classification, which can facilitate the optimisation of treatment strategies. In addition, our study highlights the genetic features of Japanese patients with DLBCL.
引用
- Mishina T, Oshima-Hasegawa N, Tsukamoto S, et al. Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. Br J Haematol. 2021. PMID: 34378195. doi:10.1111/bjh.17765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。